NMC Health Plc (LSE:NMC) has a Value Composite score of 45. Developed by James O’Shaughnessy, the VC score uses six valuation ratios. These ratios are price to earnings, price to cash flow, EBITDA to EV, price to book value, price to sales and shareholder yield. The VC score is displayed as a number between 1 and 100. In general, a company with a score closer to 0 would be seen as undervalued, and a score closer to 100 would indicate an overvalued company. Removing the sixth ratio (shareholder yield) we can view the Value Composite 1 score which is currently sitting at 48.
Investors may be digging through all of the most recent earnings report trying to locate a few names that are poised to make a run. Investors often take notice when a company beats or misses analyst projections by a wide margin. Once identifying these stocks, investors may want to look back at earnings history over the past few quarters. While one or two sub-par quarters may not be a legitimate cause for alarm, a long string of underperformance may be worth looking into. On the flip side, one or two great quarters may not be telling the complete picture either. Going behind the curtain and investigating the numbers may help the investor locate the next batch of stocks to add to the portfolio.
We can now take a quick look at some historical stock price index data. NMC Health Plc (LSE:NMC) presently has a 10 month price index of 0.66354. The price index is calculated by dividing the current share price by the share price ten months ago. A ratio over one indicates an increase in share price over the period. A ratio lower than one shows that the price has decreased over that time period. Looking at some alternate time periods, the 12 month price index is 0.55094, the 24 month is 0.82105, and the 36 month is 1.63108. Narrowing in a bit closer, the 5 month price index is 0.99229, the 3 month is 0.83019, and the 1 month is currently 0.86211.
Watching some historical volatility numbers on shares of NMC Health Plc (LSE:NMC), we can see that the 12 month volatility is presently 44.229300. The 6 month volatility is 56.092500, and the 3 month is spotted at 62.573600. Following volatility data can help measure how much the stock price has fluctuated over the specified time period. Although past volatility action may help project future stock volatility, it may also be vastly different when taking into account other factors that may be driving price action during the measured time period.
Valuation Scores
Shifting gears, we can see that NMC Health Plc (LSE:NMC) has a Q.i. Value of 35.00000. The Q.i. Value ranks companies using four ratios. These ratios consist of EBITDA Yield, FCF Yield, Liquidity, and Earnings Yield. The purpose of the Q.i. Value is to help identify companies that are the most undervalued. Typically, the lower the value, the more undervalued the company tends to be.
At the time of writing, NMC Health Plc (LSE:NMC) has a Piotroski F-Score of 6. The F-Score may help discover companies with strengthening balance sheets. The score may also be used to spot the weak performers. Joseph Piotroski developed the F-Score which employs nine different variables based on the company financial statement. A single point is assigned to each test that a stock passes. Typically, a stock scoring an 8 or 9 would be seen as strong. On the other end, a stock with a score from 0-2 would be viewed as weak.
NMC Health Plc has an M-score Beneish of -2.729843. This M-score model was developed by Messod Beneish in order to detect manipulation of financial statements. The score uses a combination of eight different variables. The specifics of the variables and formula can be found in the Beneish paper “The Detection of Earnings Manipulation”.
Investors may be interested in viewing the Gross Margin score on shares of NMC Health Plc (LSE:NMC). The name currently has a score of 2.00000. This score is derived from the Gross Margin (Marx) stability and growth over the previous eight years. The Gross Margin score lands on a scale from 1 to 100 where a score of 1 would be considered positive, and a score of 100 would be seen as negative.
NMC Health Plc (LSE:NMC) has a current MF Rank of 5803. Developed by hedge fund manager Joel Greenblatt, the intention of the formula is to spot high quality companies that are trading at an attractive price. The formula uses ROIC and earnings yield ratios to find quality, undervalued stocks. In general, companies with the lowest combined rank may be the higher quality picks. NMC Health Plc has a current ERP5 Rank of 7075. The ERP5 Rank may assist investors with spotting companies that are undervalued. This ranking uses four ratios. These ratios are Earnings Yield, ROIC, Price to Book, and 5 year average ROIC. When looking at the ERP5 ranking, it is generally considered the lower the value, the better.
Investors may be searching for various types of stocks to help diversify the portfolio. Growth stocks include shares of companies that may have the possibility of generating higher than average profit growth and revenues. These companies tend to pump earnings back into the business, and they generally expand quicker than the overall economy. Although growth stocks can be a bit riskier, they can also provide a higher level of reward down the line. Cyclical stocks consist of companies that typically will ride the wave of the overall economy. These shares tend to perform well when the economy is doing well and perform poorer when the economy is faltering.
Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with MarketBeat.com’s FREE daily email newsletter.